Is Jubilant Ingrevia Ltd (JUBLINGREA) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Jubilant Ingrevia Ltd is a average quality company .

Is Jubilant Ingrevia Ltd (JUBLINGREA) undervalued or overvalued?

The key valuation ratios of Jubilant Ingrevia Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Jubilant Ingrevia Ltd (JUBLINGREA) share price return in the past 10 years?

Data is not available for this company

Is Jubilant Ingrevia Ltd (JUBLINGREA) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Jubilant Ingrevia Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Jubilant Ingrevia Ltd (JUBLINGREA)?

Company share prices are keep on changing according to the market conditions. The current trading price of Jubilant Ingrevia Ltd (JUBLINGREA) on 17-Apr-2026 16:59:59 at 16:59 is 665.80.

What is the P/E ratio of Jubilant Ingrevia?

The latest standalone P/E ratio of Jubilant Ingrevia as of 17-Apr-2026 is 41.98.

What is the P/B ratio of Jubilant Ingrevia Ltd (JUBLINGREA)?

The latest standalone P/B ratio of Jubilant Ingrevia Ltd (JUBLINGREA) as of 17-Apr-2026 is 4.13.

What is the 52-week high and low of Jubilant Ingrevia Ltd (JUBLINGREA)?

The 52-week high of Jubilant Ingrevia Ltd (JUBLINGREA) is Rs. 851.85 and the 52-week low is Rs. 535.30.

Jubilant Ingrevia Ltd (JUBLINGREA) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Jubilant Ingrevia Ltd (JUBLINGREA)
Brand: Jubilant Ingrevia

Jubilant Ingrevia Ltd (JUBLINGREA) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 543271 NSE: JUBLINGREA | Chemicals | Small Cap

Jubilant Ingrevia Ltd (JUBLINGREA)

BSE: 543271 NSE: JUBLINGREA

Key Metrics

Market Cap

₹10,605 Cr.

P/E Ratio

41.98

Price to Book (P/B)

4.13

Price to Sales (P/S)

2.67

EV/EBITDA

20.61

Return on Capital Employed (ROCE)

12.96%

Current Price

₹665.8

Return on Equity (ROE)

11.30%

Return on Assets (ROA)

5.95%

Operating Profit Margin

12.2%

Net Profit Margin

6.68%

Gross Profit Margin

12.5%

Book Value per Share

₹161.3

Sales Growth (YoY)

-1.15%

Sales Growth (3 Years)

-6.75%

Operating Profit Growth (1 Year)

17.82%

Operating Profit Growth (3 Years)

-16.42%

Net Profit Growth (1 Year)

62.16%

52-Week Low / High

₹535 / 852

Net Profit Growth (3 Years)

-16.49%

Dividend Yield

0.77%

Promoter Holding

45.22%

Pledged shares (%)
of Promoter's holding (%)

7.64%

Check Before You Invest

Q.1 Revenue growth of Jubilant Ingrevia Ltd?

Jubilant Ingrevia Ltd revenue growth is -1.2% for FY-2025 , which is below its 5 year CAGR of 0% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of Jubilant Ingrevia Ltd?

Promoters hold 45.22% of the Jubilant Ingrevia Ltd, with 7.64% of their stake pledged, indicating low pledge risk.

Q.1 Revenue growth of Jubilant Ingrevia Ltd vs industry peers?

Jubilant Ingrevia Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 7.7% , indicating slower growth and losing its market share.

Q.1 Which industry/sub-sector does Jubilant Ingrevia Ltd belong to?

Jubilant Ingrevia Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.

Q.1 Stock return of Jubilant Ingrevia Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of 17.38% based on the current price.

DeciZen - make an informed investing decision on Jubilant Ingrevia

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation ⓘ

3. Price Trend

Jubilant Ingrevia stock performance

Key Ratios

Is Jubilant Ingrevia Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	0%	0%	0%	0%	0%	5.6%	30.6%	15.7%	10.5%	13%	-
Value Creation Index ⓘ	NA	NA	NA	NA	NA	-0.6	1.3	0.2	-0.2	0.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	669	4,860	4,560	3,987	3,941	3,969
Sales YoY Gr.	-	NA	NA	NA	NA	NA	626.6%	-6.2%	-12.6%	-1.2%	-
Adj EPS ⓘ	0	0	0	0	-3.3	3.1	29.1	16.7	10.6	16.8	15.9
YoY Gr.	-	NA	NA	NA	NA	NA	833.7%	-42.6%	-36.7%	58.6%	-
BVPS (₹) ⓘ	0	0	0	0	-2.3	98.9	124.4	135.3	140.5	152.2	161.3
Adj Net Profit ⓘ	0	0	0	0	-0.2	49.7	464	266	169	267	253
Cash Flow from Ops. ⓘ	0	0	0	0	0	104	587	446	394	441	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	7.1	0.7	1.4	2.1	1.8	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	-6.8%	-1.2%
Adj EPS ⓘ	NA	NA	-16.8%	58.6%
BVPSⓘ	NA	NA	6.9%	8.3%
Share Price	-	16.2%	18.2%	0.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	143.1	6.3	26.1	12.9	7.7	11.4	10.1
Op. Profit Mgn % ⓘ	0	14.9	17.1	11.3	10.3	12.2	11.7
Net Profit Mgn % ⓘ	0	7.4	9.6	5.8	4.2	6.8	6.4
Debt to Equity ⓘ	0	0.5	0.2	0.3	0.4	0.3	-
Working Cap Days ⓘ	0	334	106	128	144	147	77
Cash Conv. Cycle ⓘ	0	15	22	38	43	46	12

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	15.9	16.7
TTM Sales (₹ Cr.)	3,969	4,217
BVPS (₹) ⓘ	161.3	193.9
Reserves (₹ Cr.) ⓘ	2,553	3,072
P/BV ⓘ	4.13	3.43
PE ⓘ	41.98	39.94

From the Market
52 Week Low / High (₹)	535.30 / 851.85
All Time Low / High (₹)	243.60 / 884.95
Market Cap (₹ Cr.)	10,605
Equity (₹ Cr.)	15.9
Face Value (₹)	1
Industry PE ⓘ	45.3

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

3.45

2.71

2.22

7.08

7.64

* Pledged shares as % of Promoter's holding (%)

Valuation of Jubilant Ingrevia - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	669	4,860	4,560	3,987	3,941
Operating Expenses ⓘ +	0	572	4,047	4,065	3,584	3,466
Manufacturing Costs	0	113	731	1,025	827	771
Material Costs	0	388	2,868	2,537	2,150	2,088
Employee Cost	0	43	292	306	345	376
Other Costs ⓘ	0	28	156	198	263	231
Operating Profit ⓘ	-0	97	813	495	403	475
Operating Profit Margin (%)	-	14.5%	16.7%	10.8%	10.1%	12.0%
Other Income ⓘ +	0	2	29	31	36	81
Exceptional Items ⓘ	0	-13	0	0	0	0
Interest ⓘ	0	9	46	38	66	65
Depreciation ⓘ	0	21	120	120	133	147
Profit Before Tax ⓘ	-0	56	675	368	239	343
Tax ⓘ	0	17	223	114	77	80
Profit After Tax	-0	39	452	253	162	263
PAT Margin (%)	-	5.8%	9.3%	5.6%	4.1%	6.7%
Adjusted EPS (₹)	-3.3	2.4	28.4	15.9	10.2	16.5
Dividend Payout Ratio (%)	0%	14%	18%	31%	49%	30%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	-0	1,576	1,982	2,155	2,238	2,424
Share Capital ⓘ	0	16	16	16	16	16
Reserves ⓘ	-0	1,560	1,966	2,139	2,222	2,408
Debt +	0	647	425	601	805	704
Long Term Debt	0	647	296	337	396	350
Short Term Debt	0	0	129	263	409	354
Minority Interest	0	0	0	0	0	0
Trade Payables	0	690	795	810	757	796
Others Liabilities ⓘ	0	327	451	493	541	597
Total Liabilities ⓘ	0	3,240	3,652	4,058	4,340	4,521
Fixed Assets
Net Fixed Assets ⓘ +	0	1,727	1,728	1,775	2,292	2,335
Gross Block	0	2,235	2,350	2,507	3,142	3,304
Accumulated Depreciation	0	508	622	731	850	968
CWIP ⓘ	0	65	167	477	181	197
Investments ⓘ	0	135	139	172	297	310
Inventories	0	521	763	880	775	804
Trade Receivables	0	480	585	497	563	573
Cash Equivalents	0	86	24	37	20	51
Others Assets ⓘ	0	227	247	221	213	250
Total Assets ⓘ	0	3,240	3,652	4,058	4,340	4,521

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0	104	587	446	394	441
PBT ⓘ	-0	56	675	368	239	343
Adjustment ⓘ	0	47	179	160	211	176
Changes in Working Capital ⓘ	0	12	-156	-10	-23	-5
Tax Paid ⓘ	0	-11	-111	-72	-33	-74
Cash Flow From Investing Activity ⓘ +	0	-29	-221	-475	-464	-211
Capex	0	-27	-222	-443	-339	-203
Net Investments	0	0	0	0	0	-8
Others ⓘ	0	-2	1	-32	-125	-0
Cash Flow From Financing Activity ⓘ +	0	-70	-410	33	64	-208
Net Proceeds from Shares ⓘ	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	-62	-443	58	192	-65
Interest Paid ⓘ	0	-8	-48	-60	-82	-81
Dividend Paid ⓘ	0	0	-45	-79	-79	-80
Others ⓘ	0	-0	126	114	33	17
Net Cash Flow ⓘ	0	5	-44	3	-6	22

Finance Ratio

PARTICULARS	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	N/A	4.9	25.43	12.25	7.4	11.3
ROCE (%)	N/A	5.62	30.58	15.71	10.46	12.96
Asset Turnover Ratio	0	0.41	1.41	1.18	0.95	0.89
PAT to CFO Conversion(x)	N/A	2.67	1.3	1.76	2.43	1.68
Working Capital Days
Receivable Days	0	261	40	43	49	53
Inventory Days	0	283	48	66	76	73
Payable Days	0	325	94	115	133	136

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Jubilant Ingrevia Ltd FAQs

The current trading price of Jubilant Ingrevia on 17-Apr-2026 16:59 is ₹665.8.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Jubilant Ingrevia stood at ₹10,604.9 Cr

The latest P/E ratio of Jubilant Ingrevia as of 16-Apr-2026 is 41.98.

The latest P/B ratio of Jubilant Ingrevia as of 16-Apr-2026 is 4.13.

The 52-week high of Jubilant Ingrevia is ₹851.9 and the 52-week low is ₹535.3.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jubilant Ingrevia is ₹3,969 ( Cr.) .

About Jubilant Ingrevia Ltd

Jubilant Ingrevia is a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with its customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia is the demerged pharma and life sciences business of Jubilant Lifesciences and listed on the exchanges in FY21.

Business area of the company

The company offers a broad portfolio of high-quality ingredients that find application in a wide range of industries. The company’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.

Product and services

Speciality Chemicals

Speciality Ingredients
Fine Chemicals
Crop Protection Chemicals
CDMO

Nutrition & Health Solutions

Nutrition & Health Ingredients
Animal Nutrition & Health Solutions
Human Nutrition & Health Solutions

Life Science Chemicals

Life Science Ingredients
Speciality Ethanol

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Jubilant Ingrevia Ltd (JUBLINGREA) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Jubilant Ingrevia Share Price